Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

BACKGROUND: Prognostic factors in locally advanced breast cancer treated with neoadjuvant chemotherapy differ from those of early breast cancer. The purpose of this study was to identify the clinical significance of potential predictive and prognostic factors in breast cancer patients treated by neo...

Descripción completa

Detalles Bibliográficos
Autores principales: Keam, Bhumsuk, Im, Seock-Ah, Kim, Hee-Jun, Oh, Do-Youn, Kim, Jee Hyun, Lee, Se-Hoon, Chie, Eui Kyu, Han, Wonshik, Kim, Dong-Wan, Moon, Woo Kyung, Kim, Tae-You, Park, In Ae, Noh, Dong-Young, Heo, Dae Seog, Ha, Sung Whan, Bang, Yung-Jue
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2217558/
https://www.ncbi.nlm.nih.gov/pubmed/17976237
http://dx.doi.org/10.1186/1471-2407-7-203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2217558/
https://www.ncbi.nlm.nih.gov/pubmed/17976237
http://dx.doi.org/10.1186/1471-2407-7-203

Ejemplares similares